Contrary to his testimony, Representative Tom Price (R-Ga.), President Donald Trump's pick to head the US Department of Health and Human Services, received a special price on shares of Innate Immunotherapeutics, the Wall Street Journal reports.
Registering provides access to this and other free content.
Already have an account?Login Now.
NPR reports that Turkish high school students will no longer study evolution.
Researchers report they sequenced and identified plant species in an "al fresco" laboratory.
An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.
In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.